Health & Biotech
Apiam Animal Health (ASX:AHX) is comprised of Australia’s leading Production Animal and Mixed Animal veterinary practices.
Apiam Animal Health incorporates over 150 highly experienced, industry leading veterinarians with expertise across pig, dairy, feedlot, sheep, poultry, equine, and companion animal sectors, supported by an experienced administration, nursing, technical services and ancillary team.
Apiam Animal Health is fully vertically integrated, including having veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.
What sets Apiam apart is shared expertise and professional collaboration across the business.
We believe that local knowledge is global knowledge and apply this philosophy across all our businesses from vet clinic, to production animal consultancy, logistics and laboratory with our vets and allied staff sharing expertise and specialist knowledge.
We collaborate and consult across Apiam businesses to deliver the best outcomes for the animals in our care. We are focussed on meeting the needs of our clients and shaping the future of the industry to deliver best practice animal welfare at a local level and nationally.
The name Apiam Animal Health and the logo for the company were inspired by the honey bee, which belongs to the Genus Apis.
Bees are symbolic of a team working towards a common goal. They are seen as industrious, hard-working characteristics: creating wonderfully efficient, meticulous, hexagonal hives.
Hexagons form a repetitive pattern, common in nature due to scalability while maintaining their robustness and strength.
It is Apiam Animal Health’s goal that all clinics, businesses and employee’s will work together towards a common goal, developing its team and building a successful, inspiring and strong company.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Market highlights and ASX small caps to watch on Wednesday
IPO Watch
IPO Watch: Online petcare marketplace Mad Paws launches $10m ASX listing
Stockhead TV
Post-pandemic winners – who’s taking advantage in the new normal?
Tech
Post-COVID winners: The ASX players looking for more growth in 2021
Health & Biotech
Apiam pounces on a generational market opportunity amid booming growth in regional Australia
Health & Biotech
Your ultimate guide to ASX pet stocks
Health & Biotech
How a leading Apiam vet clinic converted the COVID-19 crisis into a 20pc boost in revenues
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Apiam snaps up key vet acquisition to capitalise on post-Covid tailwinds
Health & Biotech
For Apiam, being an employer of choice is crucial to its competitive advantage
Health & Biotech
Apiam gives Aussie farmers a boost with new piglet survival treatment
Health & Biotech
Apiam finds dual tailwinds in the market for custom animal health vaccines
Health & Biotech
Apiam shares rally on strong Q1 numbers amid surging growth in pet ownership
Health & Biotech
The ASX small caps looking to capitalise on post-COVID trends in animal health
Health & Biotech
Health Kick Podcast: Investors love Apiam’s diversified pet and livestock vet offering
Health & Biotech
Investors bullish on Apiam as ‘headwinds turn to tailwinds’
News